Our expert panel will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including:
– Histopathology as a treatment target in IBD: Aspiration or Reality?
– Measuring histopathology in IBD trials
– Histopathology as a treatment target in NASH trials
– Measuring histopathology in NASH trials
Join our community of smart and fun people from across the world who generously share their ideas, learnings, and resources with each other. We’ll also, send a short summary directly to your inbox never more than once a week.
© 2024 Marketboats Consulting, Inc. All Rights Reserved.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to our use of all cookies, however, you may visit “Cookies Setting” to provide a controlled consent.